C12N 2760/16163
By chemical treatment
Official title: by chemical treatment
C12N2760/16163 (By chemical treatment) appears on 51 US grants and 70 published applications in this corpus.
Search patents in C12N- Granted patents
- 51
- Published applications
- 70
- Assignees
- 45
- Inventors
- 121
- Latest grant
- 7 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 2 |
| 2004 | 1 | 2 |
| 2005 | 1 | 3 |
| 2006 | 0 | 1 |
| 2007 | 2 | 2 |
| 2008 | 0 | 4 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 1 | 4 |
| 2012 | 3 | 2 |
| 2013 | 2 | 2 |
| 2014 | 2 | 4 |
| 2015 | 1 | 2 |
| 2016 | 2 | 4 |
| 2017 | 1 | 2 |
| 2018 | 2 | 6 |
| 2019 | 3 | 2 |
| 2020 | 4 | 1 |
| 2021 | 2 | 4 |
| 2022 | 3 | 7 |
| 2023 | 4 | 4 |
| 2024 | 2 | 3 |
| 2025 | 5 | 4 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Viral vaccines and methods of forming the same7 Oct 2025US 12,435,317 B2NDSU Research Foundation
- Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production23 Sep 2025US 12,419,947 B2Najit Technologies, Inc.
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof12 Aug 2025US 12,385,068 B2Boehringer Ingelheim Animal Health USA Inc.
- Recombinant influenza viruses with stabilized NA22 Jul 2025US 12,365,880 B2The University of Tokyo
- Preparation of influenza virus vaccine antigens3 Jun 2025US 12,318,442 B2Seqirus UK Limited
- Preparation of influenza virus vaccine antigens19 Feb 2026US 2026/0048115 A1Seqirus UK Limited
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof30 Oct 2025US 2025/0333766 A1Boehringer Ingelheim Animal Health USA Inc.
- Recombinant influenza viruses with stabilized na4 Sep 2025US 2025/0277192 A1The University of Tokyo
- Multipurpose Compositions for Collecting and Transporting Biological Material14 Aug 2025US 2025/0257330 A1Longhorn Vaccines and Diagnostics, LLC
- Thermostable uv inactivated vaccines and other biopharmaceuticals5 Jun 2025US 2025/0177534 A1Universal Stabilization Technologies, Inc.
Most cited
By later US patents
- DNA transfection system for the generation of infectious influenza virus91US 6,951,754 B2St. Jude Children?S Research Hospital · 2005
- Method for producing viruses and vaccines in serum-free culture87US 5,753,489 AImmuno Aktiengesellschaft · 1998
- DNA transfection system for the generation of infectious influenza virus45US 7,312,064 B2St. Jude Children's Research Hosptal · 2007
- DNA-transfection system for the generation of infectious influenza virus41US 7,972,843 B2St. Jude Children?S Research Hospital · 2011
- Process for obtaining lipid envelope virus sub-units, notably antigens for use as vaccines, the products obtained and their applications35US 4,522,809 AInstitut Pasteur · 1985